CRISPR Therapeutics Vertex Pharmaceuticals: Better Buy in 2026
Investors face a choice between a high-growth gene-editing bet and a cash-generating biotech leader. This article bre...
Stock indices exist to track market performance and guide investment decisions. Learn their purpose, construction, and practical uses.
22,537 articlesInvestors face a choice between a high-growth gene-editing bet and a cash-generating biotech leader. This article bre...
Tesla faces a pivotal test as its stock trades near a multi-trillion dollar valuation. The company posted solid quart...
Between Dec 31, 2025 and July 10, 2026, the Global X AI & Technology ETF rose about 24.74%, while Arista Networks cli...
PayPal sits near $42 after a tough year, sparking a lively debate on whether the stock is a bargain or a trap as Q4 r...
AutoZone beat on revenue but missed top-line estimates, while margins narrowed and shares fell. The focus: margins cr...
Tesla stock has slid about 18% from its December peak as deliveries declined and autonomy safety metrics raise questi...
A growing chorus of advisors is championing a three-ETF approach as a simple, disciplined path to retirement wealth. ...
JetBlue jumped 18% after announcing a multi-year partnership with Boston Legacy FC as the official airline, while Del...
Qualcomm exploded higher, gaining about 70% in a single month as it pivots toward AI data-center demand. Investors ar...
U.S. stocks edge lower as Iran tensions escalate, with the SPY and major indexes slipping while oil climbs and safe-h...
Royal Caribbean Cruises posted stronger-than-expected Q1 results, boosting its 2026 EPS outlook as demand for cruises...
As AI data centers ramp up, two independent power producers headline the market: Constellation Energy and Vistra. Thi...